Literature DB >> 24933448

Clinical utility of caspofungin eye drops in fungal keratitis.

Chin Fen Neoh1, Mark Daniell2, Sharon C-A Chen3, Kay Stewart4, David C M Kong5.   

Abstract

Treatment of fungal keratitis remains challenging. To date, only the polyenes and azoles are commonly used topically in the management of fungal keratitis. Natamycin, a polyene, is the only antifungal eye drop that is commercially available; the remainder are prepared in-house and are used in an 'off-label' manner. Failure of medical treatment for fungal keratitis is common, hence there is a need for more effective topical antifungal therapy. To increase the antifungal eye drop armamentarium, it is important to investigate the utility of other classes of antifungal agents for topical use. Caspofungin, an echinocandin antifungal agent, could potentially be used to address the existing shortcomings. However, little is known about the usefulness of topically administered caspofungin. This review will briefly explore the incidence, epidemiology and antifungal treatment of fungal keratitis. It will focus primarily on evidence related to the efficacy, safety and practicality of using caspofungin eye drops in fungal keratitis.
Copyright © 2014 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Keywords:  Caspofungin; Corneal ulcer; Cost; Echinocandins; Keratomycosis

Mesh:

Substances:

Year:  2014        PMID: 24933448     DOI: 10.1016/j.ijantimicag.2014.04.008

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  12 in total

1.  Multidrug-resistant Fusarium keratitis: diagnosis and treatment considerations.

Authors:  Sergio Sara; Kendall Sharpe; Sharon Morris
Journal:  BMJ Case Rep       Date:  2016-08-03

2.  Open-Label Study of Absorption and Clearance of 1% Voriconazole Eye Drops.

Authors:  Chin Fen Neoh; Lok Leung; Elsie Chan; Daoud Al-Badriyeh; Robert O Fullinfaw; Vishal Jhanji; Rasik B Vajpayee; Geoffrey E Davies; Kay Stewart; David C M Kong
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

Review 3.  Review of clinical and basic approaches of fungal keratitis.

Authors:  Jie Wu; Wen-Song Zhang; Jing Zhao; Hong-Yan Zhou
Journal:  Int J Ophthalmol       Date:  2016-11-18       Impact factor: 1.779

4.  Natamycin in the treatment of fungal keratitis: a systematic review and Meta-analysis.

Authors:  Sheng Qiu; Gui-Qiu Zhao; Jing Lin; Xue Wang; Li-Ting Hu; Zhao-Dong Du; Qian Wang; Cheng-Cheng Zhu
Journal:  Int J Ophthalmol       Date:  2015-06-18       Impact factor: 1.779

5.  The facilitating effect of blue light on the antifungal agent susceptibilities of passaged conidia from the ocular-derived Fusarium solani species complex.

Authors:  Yujie Cen; Yingyu Li; Pei Zhang; Ziyuan Liu; Chen Huang; Wei Wang
Journal:  Lasers Med Sci       Date:  2022-01-29       Impact factor: 3.161

Review 6.  Challenges in the Polyene- and Azole-Based Pharmacotherapy of Ocular Fungal Infections.

Authors:  Prit Lakhani; Akash Patil; Soumyajit Majumdar
Journal:  J Ocul Pharmacol Ther       Date:  2018-11-08       Impact factor: 2.671

7.  Fungal Keratitis Caused by Candida orthopsilosis Successfully Treated with Caspofungin.

Authors:  Tae Hwan Kim; Ikhyun Jun; Hyung Keun Lee; Kyoung Yul Seo; Tae Im Kim; Eung Kweon Kim
Journal:  Korean J Ophthalmol       Date:  2020-08

8.  Analysis of differentially expressed genes in bacterial and fungal keratitis.

Authors:  Rui Tian; He Zou; Lufei Wang; Lu Liu; Meijiao Song; Hui Zhang
Journal:  Indian J Ophthalmol       Date:  2020-01       Impact factor: 1.848

9.  Case Report: Successful Management of Refractory Keratomycosis in an Alpaca Using Penetrating Keratoplasty and Combination Antifungal Therapy (Caspofungin 0.5% and Terbinafine 1%).

Authors:  Braidee C Foote; Joe S Smith; Anna Catherine Bowden; Rachel A Allbaugh; Lionel Sebbag
Journal:  Front Vet Sci       Date:  2021-03-11

10.  1,25(OH)2D3 and VDR Signaling Pathways Regulate the Inhibition of Dectin-1 Caused by Cyclosporine A in Response to Aspergillus Fumigatus in Human Corneal Epithelial Cells.

Authors:  Yiping Xia; Guiqiu Zhao; Jing Lin; Cui Li; Lin Cong; Nan Jiang; Qiang Xu; Qian Wang
Journal:  PLoS One       Date:  2016-10-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.